|
Excess intermediate risk nonseminoma and regional lymph node metastases at presentation in patients with Hispanic germ cell tumor. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Justin Wayne Wong Tiu-lim |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Taris |
Honoraria - Aduro Biotech; Allergan (I); Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; Ferring; Janssen Oncology; Johnson & Johnson; Olympus; pacific edge; Pfizer; Photocure; Protara Therapeutics; QED Therapeutics |
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris |
Research Funding - Photocure |
Travel, Accommodations, Expenses - Janssen Oncology; Photocure |
|
|
Honoraria - pacific edge; Photocure |
Consulting or Advisory Role - Fergene; Gerson Lehrman Group; Pacific Edge Biotechnology; Pacific Edge Biotechnology; Photocure |
Speakers' Bureau - Photocure |
|
|
No Relationships to Disclose |
|
|
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |